期刊
JOURNAL OF IMMUNOLOGY
卷 176, 期 8, 页码 4923-4930出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.176.8.4923
关键词
-
类别
资金
- NHLBI NIH HHS [HL61419, HL66196] Funding Source: Medline
We investigated the impact of inflammatory signaling in airway epithelial cells on host defense against Pseudomonas aeruginosa, a major cause of nosocomial pneumonia. In mice, airway instillation of P. aeruginosa resulted in NF-kappa B activation in the lungs that was primarfly localized to the bronchial epithelium at 4 h, but was present in a variety of cell types by 24 h. We modulated NF-kappa B activity in airway epithelium by intratracheal delivery of adenoviral vectors expressing RelA (AdRelA) or a dominant inhibitor of NF-kappa B before P. aeruginosa infection. Bacterial clearance was enhanced by up-regulation of NF-kappa B activity following AdRelA administration and was impaired by treatment with a dominant inhibitor of NF-kappa B. The TNF-alpha concentration in lung lavage was increased by AdRelA treatment and beneficial effects of NF-kappa B up-regulation were abrogated in TNF-alpha-deficient mice. In contrast, NF-kappa B inhibition reduced MIP-2 expression and neutrophil influx following P. aeruginosa infection. Therefore, inflammatory signaling through the NF-kappa B pathway in airway epithelial cells critically regulates the innate immune response to P. aeruginosa.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据